To determine if Cds2 vMO treatments have direct effects on tumor cell proliferation, we exposed isolated B16-F10 or LLC cells in vitro to the estimated comparable doses of Cds2 vMO that they would encounter in vivo and measured proliferation rates. Here, CDS2 is linked to neoplasm.